- Home
- APLD vs RNA Comparison
APLD vs RNA Comparison
Compare APLD & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | APLD | RNA |
|---|---|---|
| Founded | 2001 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 4.0B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | APLD | RNA |
|---|---|---|
| Price | $31.32 | $71.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 20 |
| Target Price | $29.36 | ★ $69.26 |
| AVG Volume (30 Days) | ★ 27.3M | 2.9M |
| Earning Date | 01-13-2026 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $173,560,000.00 | $20,868,000.00 |
| Revenue This Year | $113.90 | $64.11 |
| Revenue Next Year | $71.28 | $37.25 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 28.43 | ★ 106.27 |
| 52 Week Low | $3.31 | $21.51 |
| 52 Week High | $40.20 | $71.79 |
Technical Indicators
Market Signals| Indicator | APLD | RNA |
|---|---|---|
| Relative Strength Index (RSI) | 61.45 | 77.56 |
| Support Level | $26.86 | $71.42 |
| Resistance Level | $30.30 | $71.76 |
| Average True Range (ATR) | 2.52 | 0.41 |
| MACD | 0.92 | -0.73 |
| Stochastic Oscillator | 93.98 | 88.32 |
Price Performance
Historical ComparisonAbout APLD Applied Digital Corporation
Applied Digital Corp is a designer, developer, and operator of next-generation digital infrastructure across North America. It provides digital infrastructure solutions and cloud services to industries like High-Performance Computing (HPC) and Artificial Intelligence (AI). The company operates in the following business segments: Data Center Hosting Business and HPC Hosting Business. The majority of its revenue is generated from the Data Center Hosting Business, which operates data centers to provide energized space to crypto mining customers.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.